DEX improved early postoperative cognitive decline in OLV rats to some extent, and its mechanism included improving oxygen supply to brain tissue during OLV, stabilizing synapses in the hippocampal CA1 region, and upregulating the anti-apoptotic ERK1/2-CREB-Bcl-2 signaling pathway. The gene discussed is MAPK3; the disease is Mental deterioration.